Atom Educacao E Editora S.A. (ATED3M)

Seth Lederman bought 5,000 common shares at $11.79 each in open-market purchases.
His directly held stake rose to 9,005 common shares.
He also reported 20,002 common shares held indirectly, including 20,001 via an IRA account.

Nice try pal, such a weak argument about the CEO with nothing of substance to back it up. There is NOTHING wrong with updates from company on Twitter. 100s of companies use social media to heighten brand awareness. Jeez get a clue man, that's the way companies reach the investment community in 2026.

The formation of aggregated short chains in the bulk of the crude oil plays a similar function as the addition of drag reducing agents to the crude oil.

The addition of DRA causes further issues at the oil refineries.

The most significant aspect of this technology is

Do It Today!

In a class I teach for young adults, I gave the assignment to "go to someone you love, and tell them that you love them." At the beginning of the next class, one of the students began by saying, "I was angry with you last week when you gave us this assignment. I didn't fe

🚨 $RITR Flying under the radar~~Global logistics & supply chain play

💰 Strategic investment agreement worth up to $60M
📈 Massive volume expansion
👀 Social engagement exploding
🏗️ Built structure after the first move instead

🚨 $RITR Flying under the radar~~Global logistics & supply chain play

💰 Strategic investment agreement worth up to $60M
📈 Massive volume expansion
👀 Social engagement exploding
🏗️ Built structure after the first move instead

Rock Tech Lithium Shares Begin Trading on Xetra in GermanyJune 12, 2026 4:00 AM
PR Newswire (Canada) Strengthening presence in global capital markets with combination of listing in Canada and planned trading on NASDAQRock Tech

All the GEMS & FACTS are in the latest 10Q filing.


We are now focusing on a potential sale of 150 units as an initial purchase order under the so-called Laksel LOI (discussed below). This represents a defined India focused initial program within our broader framework, targetin

$PAVS WEEEEEEEEEEEEEEEEEEEEEEEE 🚀🚀🚀🚀🔥🔥🔥🔥🔥🔥🔥🔥🚀

PAVS and HKIT HKIT too ,  both should run hard today. 🔥
imho

Woohoo! I’m loving being an early investor. I’ve owned Fidelity Contra Fund for many years which holds a 5% stake in pre-IPO shares! Any other FCNTX holders here? If so…did you see the CNBC article out today that mentions FCNTX??

I am pleased to announce the Nomination of very Highly Respected Jay Clayton, former Chairman of the Securities and Exchange Commission, the former Head of Sullivan & Cromwell, one of the most prominent and successful Law Firms anywhere in the World, and the current United States Attorney for the So

I am somewhat surprised that there has been no action from the authorities on this scam, yet. The other scam that I have been following and hopefully helping to expose is the Astra/Holcomb(also on ADVFN) where an FBI raid was carried out ~1year ago and the FBI are actively looking for scammed invest

EMBR YEP!

EMBR YEP!

EMBR Is a very RARE gem. X is going crazy of it. Here’s another X post…

https://x.com/beardtrader1178/status/2065313802606760085?s=46

EMBR Is a very RARE gem. X is going crazy of it. Here’s another X post…

https://x.com/beardtrader1178/status/2065313802606760085?s=46

Vertical Data and Quantum eMotion Partner to Bring Quantum Cybersecurity to AI Infrastructure DeploymentsJune 12, 2026 3:00 AM
Newsfile

$AMC GREAT NEWS! $65 SHORT TERM TARGET!

https://youtu.be/POTxAjR9zXw?si=MhP3WfvvBEVYXiFO

https://x.com/CEOAdam/status/2065056828661080534

Vertical Data and Quantum eMotion Partner to Bring Quantum Cybersecurity to AI Infrastructure DeploymentsJune 12, 2026 3:00 AM
ACCESS NewswireInitial Pilot Deployment Targeted for 2026 Across Vertical Data's GPU Cluster and Edge Data Center Pipeline

AbbVie Presents New Data at EHA 2026 Congress for VENCLEXTA®/VENCLYXTO® (venetoclax) in First-Line Chronic Lymphocytic Leukemia Highlighting Long-Term Treatment Outcomes for Patients: Nine-Year ResultsJune 12, 2026 3:00 AM
PR Newswire (US) class="legen

AbbVie Presents New Data at EHA 2026 Congress for VENCLEXTA®/VENCLYXTO® (venetoclax) in First-Line Chronic Lymphocytic Leukemia Highlighting Long-Term Treatment Outcomes for Patients: Nine-Year ResultsJune 12, 2026 3:00 AM
PR Newswire (US) class="legen

So we wait a year, or Accord scores the patent and Elite gets Tentative approval
then things might change .

SpaceX Secures $75 Billion Ahead of Historic Market DebutJune 12, 2026 2:45 AM
IH Market News SpaceX (NASDAQ:

THX, very confusing,
google says
None of these products have yet been approved by the FDA, and Elite therefore does not yet market any products. Elite Labs also engages in contract research ...Read more

no harm no foul
If they went to trial now, it would probly t